These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28971320)

  • 41. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
    Regan MM; Pagani O; Francis PA; Fleming GF; Walley BA; Kammler R; Dell'Orto P; Russo L; Szőke J; Doimi F; Villani L; Pizzolitto S; Öhlschlegel C; Sessa F; Peg Cámara V; Rodríguez Peralto JL; MacGrogan G; Colleoni M; Goldhirsch A; Price KN; Coates AS; Gelber RD; Viale G;
    Breast Cancer Res Treat; 2015 Nov; 154(2):275-86. PubMed ID: 26493064
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical outcome of receptor expression discordance between primary and metastatic breast cancer].
    Mu YX; Zhang P; Ma F; Yuan P; Wang JY; Xu BH; Li Q
    Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):506-511. PubMed ID: 30060358
    [No Abstract]   [Full Text] [Related]  

  • 44. Combined Estrogen Receptor and Progesterone Receptor Level Can Predict Survival Outcome in Human Epidermal Growth Factor Receptor 2-positive Early Breast Cancer.
    Chen M; Wu J; Liu D; Chen W; Lin C; Andriani L; Ding S; Huang O; He J; Chen X; Chen W; Li Y; Shen K; Zhu L
    Clin Breast Cancer; 2022 Feb; 22(2):e147-e156. PubMed ID: 34244052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
    Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
    Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases.
    Peng L; Zhang Z; Zhao D; Zhao J; Mao F; Sun Q
    Pathol Oncol Res; 2021; 27():599894. PubMed ID: 34257555
    [No Abstract]   [Full Text] [Related]  

  • 47. Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.
    Ding J; Kuo ML; Su L; Xue L; Luh F; Zhang H; Wang J; Lin TG; Zhang K; Chu P; Zheng S; Liu X; Yen Y
    Carcinogenesis; 2017 May; 38(5):519-531. PubMed ID: 28379297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Obesity associated alterations in the biology of adipose stem cells mediate enhanced tumorigenesis by estrogen dependent pathways.
    Strong AL; Strong TA; Rhodes LV; Semon JA; Zhang X; Shi Z; Zhang S; Gimble JM; Burow ME; Bunnell BA
    Breast Cancer Res; 2013; 15(5):R102. PubMed ID: 24176089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.
    Cheng Q; Chang JT; Geradts J; Neckers LM; Haystead T; Spector NL; Lyerly HK
    Breast Cancer Res; 2012 Apr; 14(2):R62. PubMed ID: 22510516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High expression of LMTK3 is an independent factor indicating a poor prognosis in estrogen receptor α-positive breast cancer patients.
    Asano T; Sato S; Yoshimoto N; Endo Y; Hato Y; Dong Y; Takahashi S; Fujii Y; Toyama T
    Jpn J Clin Oncol; 2014 Oct; 44(10):889-97. PubMed ID: 25163465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relationships of ESR1 and XBP1 expression in human breast carcinoma and stromal cells isolated by laser capture microdissection compared to intact breast cancer tissue.
    Andres SA; Wittliff JL
    Endocrine; 2011 Oct; 40(2):212-21. PubMed ID: 21858728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expressions of ER, PR, HER-2, COX-2, and VEGF in primary and relapsed/metastatic breast cancers.
    Sun L; Yu DH; Sun SY; Zhuo SC; Cao SS; Wei L
    Cell Biochem Biophys; 2014 Apr; 68(3):511-6. PubMed ID: 23955549
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
    Luoh SW; Ramsey B; Park B; Keenan E
    Breast J; 2014; 20(1):46-52. PubMed ID: 24261828
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen and Progesterone Expression in Colorectal Carcinoma: A Clinicopathological Study.
    Abd ElLateef AAE; Mohamed AES; Elhakeem AA; Ahmed SF
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1155-1162. PubMed ID: 32334485
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AR pathway activity correlates with AR expression in a HER2-dependent manner and serves as a better prognostic factor in breast cancer.
    Liu D
    Cell Oncol (Dordr); 2020 Apr; 43(2):321-333. PubMed ID: 31933152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tumor-specific CAP1 expression and body constitution on clinical outcomes in patients with early breast cancer.
    Bergqvist M; Elebro K; Sandsveden M; Borgquist S; Rosendahl AH
    Breast Cancer Res; 2020 Jun; 22(1):67. PubMed ID: 32560703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
    Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. cMET and phospho-cMET protein levels in breast cancers and survival outcomes.
    Raghav KP; Wang W; Liu S; Chavez-MacGregor M; Meng X; Hortobagyi GN; Mills GB; Meric-Bernstam F; Blumenschein GR; Gonzalez-Angulo AM
    Clin Cancer Res; 2012 Apr; 18(8):2269-77. PubMed ID: 22374333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
    Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
    Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hormone Receptor Expression in Multicentric/Multifocal versus Unifocal Breast Cancer: Especially the VDR Determines the Outcome Related to Focality.
    Zati Zehni A; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31731733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.